CBHD.F Coloplast A/S

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
71.06 EUR
Close of Nov 11, 2026
49.72 77.19
Market cap
EUR 14.7B
P/E
37.4x
P/B
7.70x
ROE
21.5%
Dividend yield
4.71%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Sep 2026.

Is CBHD.F undervalued?

Graham number

The Graham number of Coloplast A/S cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Coloplast A/S fundamental analysis

No fundamental analysis for Coloplast A/S yet.

Coloplast A/S stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Coloplast A/S

Coloplast A/S develops and sells intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through five segments: Chronic Care, Voice & Respiratory Care, Interventional Urology, Advanced Wound Dressings, and Biologics. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of ostomies; and SenSura Ostomy care soluti…

Full company profile